PETALING JAYA: OB Holdings Berhad (“OB Holdings” or the “Company”), a leading fortified food and beverages (“F&B”) and dietary supplements manufacturing services provider in Malaysia, provided clarification regarding the ongoing legal proceedings initiated by Nature One Dairy (Hong Kong) Limited (“NOD”) against its wholly-owned subsidiary, Orient Biotech Sdn. Bhd. (“Orient Biotech”).
The Company acknowledges the receipt of a Writ of Summons and Statement of Claim filed by NOD in the Supreme Court of Victoria, Melbourne, Australia. The claims relate to alleged breaches of contract and infringement of intellectual property rights. However, OB Holdings firmly maintains that the allegations are without basis, as the product in question differs from NOD’s offerings and does not infringe on any proprietary intellectual property.
Orient Biotech received a letter from NOD’s solicitors on 4 March 2025, accompanied by a sealed Writ of Summons and an incomplete Statement of Claim, both dated 28 February 2025. A revised Statement of Claim was subsequently received on 5 March 2025. NOD is seeking unspecified damages, an account of profits or equitable compensation, interest under section 101 of the Supreme Court Act 1986, and any other reliefs the Court deems appropriate.
The Company is taking all necessary legal steps to address this matter and has engaged legal representatives in Melbourne to file its defence. Given the absence of a specified damages amount, there is no immediate financial or operational impact on OB Holdings. The Company remains confident in its position and is committed to protecting its business interests.
